Twin Capital Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.15M Sell
8,495
-25
-0.3% -$8.83K 0.33% 64
2026
Q2
$3.06M Buy
+8,520
New +$2.6M 0.33% 71
2024
Q1
– Sell
-1,830
Closed -$644K – 298
2023
Q4
$644K Hold
1,830
– – 0.08% 206
2023
Q3
$687K Sell
1,830
-154
-8% -$59.6K 0.1% 194
2023
Q2
$759K Sell
1,984
-18
-0.9% -$6.43K 0.1% 195
2023
Q1
$694K Sell
2,002
-132
-6% -$38.6K 0.09% 204
2022
Q4
$502K Sell
2,134
-1,306
-38% -$309K 0.07% 242
2022
Q3
$847K Sell
3,440
-11,803
-77% -$3.6M 0.11% 193
2022
Q2
$4.61M Sell
15,243
-211
-1% -$68.7K 0.59% 38
2022
Q1
$6.35M Sell
15,454
-1,080
-7% -$423K 0.68% 30
2021
Q4
$7.76M Buy
16,534
+880
+6% +$379K 0.78% 23
2021
Q3
$6.65M Sell
15,654
-1,850
-11% -$780K 0.68% 28
2021
Q2
$6.29M Buy
17,504
+8,764
+100% +$2.9M 0.58% 42
2021
Q1
$2.46M Buy
8,740
+1,340
+18% +$384K 0.25% 129
2020
Q4
$2.1M Buy
7,400
+1,410
+24% +$396K 0.19% 141
2020
Q3
$1.65M Buy
+5,990
New +$1.59M 0.15% 166
2018
Q4
– Sell
-4,005
Closed -$494K – 328
2018
Q3
$494K Buy
+4,005
New +$449K 0.02% 307

Other funds holding WST

Twin Capital Management's WST Position: Q3 2026 in Review

Twin Capital Management reduced its West Pharmaceutical (WST) stake by 0.29% in Q3 2026, selling an estimated $8.83K and leaving 8,495 shares worth $3.15M. The position accounts for 0.33% of the portfolio, ranked #64.

Twin Capital Management first reported a position in WST in Q3 2018 and has held it in 17 quarters since. The position peaked at $7.76M in Q4 2021. 875 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • Twin Capital Management held 8,495 shares of West Pharmaceutical worth $3.15M as of Q3 2026.
  • Twin Capital Management sold 25 West Pharmaceutical shares in Q3 2026, an estimated $8.83K.
  • West Pharmaceutical made up 0.33% of Twin Capital Management's portfolio in Q3 2026, its #64 holding.
  • Twin Capital Management first reported a position in West Pharmaceutical in Q3 2018 and has held it in 17 quarters since.
  • Twin Capital Management's West Pharmaceutical position peaked at $7.76M in Q4 2021.
  • 875 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Twin Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.